What to know about NAD+.

• Are allergic to NAD+ or any of its ingredients
• Are pregnant, planning to become pregnant, or breastfeeding
• Have an active or recent diagnosis of cancer (theoretical concern; discuss with your oncologist)
• Have a known history of severe asthma or hypersensitivity to vitamin B-complex compounds

The following risks should be discussed with your provider before starting and monitored throughout treatment:

• Injection-site reactions

  Mild redness, warmth, or itching at the injection site is common and usually resolves within hours.

• Flushing or chest pressure

  Some patients experience transient flushing or a feeling of chest tightness during or after injection. Inject slowly and remain seated for 5 minutes after dosing.

• Theoretical concerns with active malignancy

  Because NAD+ is required by all cells, including cancer cells, the use of NAD+ injections in patients with active cancer should be discussed with your oncologist before starting.

• Hypersensitivity reactions

  Discontinue and seek care for anaphylaxis, angioedema, or severe rash.

• Patients with kidney or liver impairment

  Your provider will assess whether NAD+ is appropriate based on your kidney and liver function.

Commonly reported side effects of NAD+ injections are typically mild and short-lived:

Symptoms typically improve with time. Your provider will adjust your dose to minimize side effects.